Results 111 to 120 of about 43,879 (232)

Recommendations for the treatment of axial spondyloarthritis: An analysis of the updated ASAS/EULAR 2022 clinical guidelines

Научно-практическая ревматология
The article discusses the 2022 updated version of the collaborative ASAS/EULAR (Assessment in SpondyloArthritis international Society/European Alliance of Associations for Rheumatology) recommendations for the treatment of axial spondyloarthritis.
Sh. F. Erdes, T. V. Dubinina
doaj   +1 more source

Validation of the Russian-language version of the ASAS Health Index

Научно-практическая ревматология, 2019
The Assessment of Spondyloarthritis International Society (ASAS) Health Index (HI) is a comprehensive tool for quantifying the health of patients with axial (ax) spondyloarthritis (SpA), including ankylosing spondylitis (AS). ASAS HI was developed on the
A. I. Akulova, A. P. Rebrov, Sh. Erdes, I. Z. Gaydukova   +3 more
doaj   +1 more source

CLINICAL SIGNIFICANCE OF CALPROTECTIN IN RHEUMATIC DISEASES

Научно-практическая ревматология, 2018
Calprotectin (CP) belongs to the S100 leukocyte protein family, consists of two calcium-binding protein molecules, S100A8 and S100A9 (MRP8/14, calgranulin A/B).
A. S. Avdeeva
doaj   +1 more source

Preliminary Validation of the Early Sacroiliitis Screening Tool (ESHST) for Identifying Hidradenitis Suppurativa Patients at High Risk of Spondyloarthritis

International Journal of Dermatology, EarlyView.
Development and preliminary validation of the Early Sacroiliitis Screening Tool (ESHST), a dermatology‐oriented screening questionnaire for identifying hidradenitis suppurativa patients at increased risk of spondyloarthritis. ABSTRACT Background Hidradenitis suppurativa (HS) is increasingly recognized as a systemic inflammatory disease associated with ...
Umut Bakay, Ozge Sevil Karstarli Bakay, Tugba Izci Duran, Niyazi Cetin   +3 more
wiley   +1 more source

Characterization and prevalence of spondyloarthritis and peripheral arthritis among patients with inflammatory bowel disease

, 2017
Hoda M Malaty,1,2 Grace Hsiao-Wei Lo,1–3 Jason K Hou1–3 1Department of Medicine, Baylor College of Medicine, 2Michael E DeBakey Veterans Affairs Medical Center, 3Center for Innovations in Quality, Effectiveness and Safety, Michael E.
Hou JK, Malaty HM, Lo GH
core  

The effect of three years of TNF alpha blocking therapy on markers of bone turnover and their predictive value for treatment discontinuation in patients with ankylosing spondylitis: a prospective longitudinal observational cohort study [PDF]

, 2012
INTRODUCTION: The aim of this study was to investigate the effect of three years of tumor necrosis factor-alpha (TNF-alpha) blocking therapy on bone turnover as well as to analyze the predictive value of early changes in bone turnover markers (BTM) for ...
Eveline van der Veer, Anneke Spoorenberg, Arends, S., Houtman, P.M., Cees G.M. Kallenberg, Leijsma, M.K., Brouwer, E., Reinhard Bos, Elisabeth Brouwer, Kallenberg, C.G., Martha K. Leijsma, Groen, H., Groen, H.; id_orcid, van der Veer, E., Bos, R., Spoorenberg, A., Henk Groen, Suzanne Arends, Pieternella M. Houtman   +18 more
core   +2 more sources

Delphi consensus: First‐line use of biologics and small molecules in hidradenitis suppurativa

Journal of the European Academy of Dermatology and Venereology, EarlyView.
This Delphi Consensus study identified upgrade criteria for the use of biologics and small molecules as first‐line therapy in hidradenitis suppurativa (HS). European HS experts evaluated 16 clinical scenarios, voting on eligibility for therapy escalation.
Georgios Nikolakis, Erkan Alpsoy, Florian Anzengruber, Matthias Augustin, Falk G. Bechara, Pierre‐André Becherel, Farida Benhadou, Vincenzo Bettoli, Joana Cabete, Raffaele Dante Caposiena Caro, Antonella Di Cesare, Giovanni Damiani, Valentina Dini, Evangelos J. Giamarellos‐Bourboulis, Krisztián Gáspár, Katalin Glasenhardt, Philippe Guillem, Ariela Hafner, Barbara Horvath, John R. Ingram, Vaiva Jarienè, Gregor B. E. Jemec, Alexander Katoulis, Natalia Kirsten, Georgios Kokolakis, Piotr K. Krajewski, Aikaterini I. Liakou, Flavia Manzo Margiotta, Angelo V. Marzano, Antonio Martorell, Lukasz Matusiak, Dillon Mintoff, Alejandro Molina Leyva, Andreas Pinter, Anna Pirogova, Maurizio Podda, Francesca Prignano, Jorge Romani, Marco Romanelli, Elia Rosi, Samed Sahin, Ditte M. L. Saunte, Sylke Schneider‐Burrus, Mariano Suppa, Jacek Szepietowski, Andrea Szegedi, Simon Francis Thomsen, Thrasyvoulos Tzellos, Anastasia Trigoni, Hessel H. Van Der Zee, Kelsey Van Straalen, Skaidra Valiukevičiene, Eva Vilarrasa, Esther von Stebut, Christos C. Zouboulis   +54 more
wiley   +1 more source

Safety and pharmacokinetics of anumigilimab for hidradenitis suppurativa or palmoplantar pustulosis: A phase 1b study

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Anumigilimab, a novel anti‐G‐CSF receptor antibody, was investigated in a phase 1b trial involving 39 patients with hidradenitis suppurativa or palmoplantar pustulosis. No serious safety concerns related to anumigilimab were noted, and PK and PD were dose dependent.
Johannes S. Kern, Simon Francis Thomsen, Georgios Kokolakis, Maurizio Podda, Gregor B. E. Jemec, Kurt Gebauer, Claus Zachariae, John Frew, Pablo Fernandez‐Peñas, Falk G. Bechara, Stefan Beissert, Sourabh Malandkar, Karen Scalzo‐Inguanti, Partha Nandy, Selvakumar Sukumar   +14 more
wiley   +1 more source

Connecting inflammation, blood vessels and bone in spondyloarthritis [PDF]

, 2022
Spondyloarthritis is one of the most frequent forms of chronic inflammatory arthritis, which affects both axial and peripheral joints. Spondyloarthritis is characterized by inflammation, new bone formation and bone destruction.
Kaaij, M.H.
core  

MAGNETIC-RESONANCE IMAGING FOR EARLY DIAGNOSIS OF COXITIS IN PATIENTS WITH SPONDYLOARTHRITIS

Научно-практическая ревматология, 2012
Objective — to define more precisely the potential of magnetic-resonance imaging (MRI) in the early diagnosis of coxitis in patients with spondyloarthritis (SpA). Material and methods.
Anna Georgievna Bochkova, A V Levshakova, E Yu Tyukhova, O A Rumyantseva, A V Smirnov, O V Pushkova, Sh F Erdes   +6 more
doaj   +1 more source